Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1104280/000144586619001219/sgbi-20190630.htm
SEC Filings
SGBI Annual Reports
SGBI Quarterly Reports
10-Q Quarterly Report May 2022
10-Q Quarterly Report February 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report February 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report February 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report May 2022
10-Q Quarterly Report February 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report February 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report February 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report May 2019
SGBI Corporate News
Event for Officers November 2015
Other Events October 2012
Financial Exhibit
Other Events September 2012
Financial Exhibit
Other Events April 2012
Financial Exhibit
Other Events April 2012
Financial Exhibit
New Agreement February 2011
Accountant Change
Financial Exhibit December 2010
Accountant Change
Financial Exhibit August 2009
Event for Officers
Financial Exhibit
Other Events October 2008
Change in Assets
Earnings Release
Event for Officers
Financial Exhibit
New Agreement
Other Events June 2008
Event for Officers
November 2015
Other Events
October 2012
Financial Exhibit
Other Events
Other Events
September 2012
Financial Exhibit
Other Events
Other Events
April 2012
Financial Exhibit
Other Events
Other Events
April 2012
Financial Exhibit
New Agreement
New Agreement
February 2011
Accountant Change
Financial Exhibit
Financial Exhibit
December 2010
Accountant Change
Financial Exhibit
Financial Exhibit
August 2009
Event for Officers
Financial Exhibit
Other Events
Financial Exhibit
Other Events
October 2008
Change in Assets
Earnings Release
Event for Officers
Financial Exhibit
New Agreement
Other Events
Earnings Release
Event for Officers
Financial Exhibit
New Agreement
Other Events
June 2008
Last10K.com | 10-K Annual Report Tue Oct 08 2019
Document and Entity Information - USD ($) | 12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2019 | Sep. 28, 2019 | Dec. 31, 2018 | |
| Details | |||
| Registrant CIK | 0001104280 | ||
| Fiscal Year End | --06-30 | ||
| Registrant Name | SANGUI BIOTECH INTERNATIONAL INC | ||
| SEC Form | 10-K | ||
| Period End date | Jun. 30, 2019 | ||
| Tax Identification Number (TIN) | 84-1330732 | ||
| Number of common stock shares outstanding | 201,479,842 | ||
| Public Float | $ 3,527,851 | ||
| Filer Category | Non-accelerated Filer | ||
| Current with reporting | Yes | ||
| Interactive Data Current | Yes | ||
| Voluntary filer | No | ||
| Well-known Seasoned Issuer | No | ||
| Shell Company | false | ||
| Small Business | true | ||
| Emerging Growth Company | false | ||
| Document Annual Report | true | ||
| Entity File Number | 0-21271 | ||
| Entity Address, State or Province | CO | ||
| Entity Incorporation, State or Country Code | CO | ||
| Entity Address, Address Line One | Neuer Wall 54 | ||
| Entity Address, City or Town | Hamburg | ||
| Entity Address, Country | DE | ||
| Entity Address, Postal Zip Code | 20354 | ||
| Country Region | 49 | ||
| City Area Code | 40 | ||
| Local Phone Number | 6093120 | ||
| Document Transition Report | false | ||
| Amendment Flag | false | ||
| Document Fiscal Year Focus | 2019 | ||
| Document Fiscal Period Focus | FY |
View differences made from one year to another to evaluate Sangui Biotech International Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Sangui Biotech International Inc.
Assess how Sangui Biotech International Inc's management team is paid from their Annual Proxy
Sangui Biotech International Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Consolidated Balance Sheets
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations And Comprehensive Income (Loss)
Consolidated Statements Of Stockholders' Equity (Deficit)
Note 1 - Organization And Summary Of Significant Accounting Policies
Note 1 - Organization And Summary Of Significant Accounting Policies (Policies)
Note 1 - Organization And Summary Of Significant Accounting Policies (Tables)
Note 1 - Organization And Summary Of Significant Accounting Policies: Basic And Diluted Loss Per Common Share (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Concentration Of Credit Risk (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Foreign Currency Translation (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Foreign Currency Translation: Schedule Of Foreign Currency Rates (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Going Concern (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Non-Controlling Interests (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Note 9 - Note Payable (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Principles Of Consolidation (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Property And Equipment (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Research And Development (Details)
Note 1 - Organization And Summary Of Significant Accounting Policies: Trade Accounts Receivable (Details)
Note 10 - Subsequent Events
Note 10 - Subsequent Events (Details)
Note 2 - License Agreement &Amp; Investment In Joint Venture
Note 2 - License Agreement &Amp; Investment In Joint Venture (Details)
Note 3 - Property And Equipment
Note 3 - Property And Equipment (Details)
Note 3 - Property And Equipment (Tables)
Note 3 - Property And Equipment: Schedule Of Property And Equipment (Details)
Note 4 - Related Party Transactions
Note 4 - Related Party Transactions (Details)
Note 5 - Stockholders' Equity
Note 5 - Stockholders' Equity (Details)
Note 6 - Income Tax Provision
Note 6 - Income Tax Provision (Details)
Note 6 - Income Tax Provision (Tables)
Note 6 - Income Tax Provision: Schedule Of Income Tax Provision (Details)
Note 7 - Commitments And Contingencies
Note 7 - Commitments And Contingencies (Details)
Note 8 - Stock-Based Compensation
Note 8 - Stock-Based Compensation (Details)
Note 9 - Note Payable
Note 9 - Note Payable (Details)
Ticker: SGBI
CIK: 1104280
Form Type: 10-K Annual Report
Accession Number: 0001445866-19-001219
Submitted to the SEC: Tue Oct 08 2019 4:29:09 PM EST
Accepted by the SEC: Tue Oct 08 2019
Period: Sunday, June 30, 2019
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/sgbi/0001445866-19-001219.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
SEC Filing Financial Summary
Excel Download
Loading SEC Filing Financial Summary...